| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viridian Therapeutics, Inc.\DE | 10%+ Owner | Common Stock | 1.51M | $31.6M | $21.00 | 23 Sep 2021 | Direct |
| Adverum Biotechnologies, Inc. | 10%+ Owner | Common Stock | 4.29M | $18.3M | $4.26 | 25 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | 25 Nov 2025 | 0 | $0 | 3 | 10%+ Owner | 05 Dec 2025, 16:41 |
| VRDN | Viridian Therapeutics, Inc.\DE | 23 Sep 2021 | 1 | $2.2M | 4 | 10%+ Owner | 28 Sep 2021, 19:46 |
| VRDN | Viridian Therapeutics, Inc.\DE | 16 Aug 2021 | 0 | $0 | 3 | 10%+ Owner | 26 Aug 2021, 13:08 |